To test this, tumor-bearing mice treated i.t. with NDV + FLt3L (versus untreated) were additionally challenged systemically (through i.v. injections of luciferase-expressing A20 cells, Fig. 4a) and followed for tumor growth and survival. This evidence concerns the gene FLT3LG and neoplasm.